Distinct roles for S. cerevisiae H2A copies in recombination and repeat stability, with a role for H2A.1 threonine 126

Abstract

CAG/CTG trinuncleotide repeats are fragile sequences that when expanded form DNA secondary structures and cause human disease. We evaluated CAG/CTG repeat stability and repair outcomes in histone H2 mutants in S. cerevisiae. Although the two copies of H2A are nearly identical in amino acid sequence, CAG repeat stability depends on H2A copy 1 (H2A.1) but not copy 2 (H2A.2). H2A.1 promotes high-fidelity homologous recombination, sister chromatid recombination (SCR), and break-induced replication whereas H2A.2 does not share these functions. Both decreased SCR and the increase in CAG expansions were due to the unique Thr126 residue in H2A.1 and hta1Δ or hta1-T126A mutants were epistatic to deletion of the Polδ subunit Pol32, suggesting a role for H2A.1 in D-loop extension. We conclude that H2A.1 plays a greater repair-specific role compared to H2A.2 and may be a first step towards evolution of a repair-specific function for H2AX compared to H2A in mammalian cells.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Nealia CM House

    Department of Biology, Tufts University, Medford, United States
    Competing interests
    No competing interests declared.
  2. Erica J Polleys

    Department of Biology, Tufts University, Medford, United States
    Competing interests
    No competing interests declared.
  3. Ishtiaque Quasem

    Department of Biology, Tufts University, Medford, United States
    Competing interests
    No competing interests declared.
  4. Marjorie De la Rosa Mejia

    Department of Biology, Tufts University, Medford, United States
    Competing interests
    No competing interests declared.
  5. Cailin E Joyce

    Department of Biology, Tufts University, Medford, United States
    Competing interests
    Cailin E Joyce, is affiliated with Agenus Inc. The author has no financial interests to declare.
  6. Oliver Takacsi-Nagy

    Department of Biology, Tufts University, Medford, United States
    Competing interests
    Oliver Takacsi-Nagy, is affiliated with ArsenalBio. The author has no financial interests to declare.
  7. Jocelyn E Krebs

    Department of Biological Sciences, University of Alaska, Anchorage, Anchorage, United States
    Competing interests
    No competing interests declared.
  8. Stephen M Fuchs

    Department of Biology, Tufts University, Medford, United States
    Competing interests
    No competing interests declared.
  9. Catherine H Freudenreich

    Department of Biology, Tufts University, Medford, United States
    For correspondence
    catherine.freudenreich@tufts.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1652-2917

Funding

National Institutes of Health (P01GM105473)

  • Catherine H Freudenreich

American Cancer Society (PF-18-125-10-DMC)

  • Erica J Polleys

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2019, House et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,145
    views
  • 159
    downloads
  • 10
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nealia CM House
  2. Erica J Polleys
  3. Ishtiaque Quasem
  4. Marjorie De la Rosa Mejia
  5. Cailin E Joyce
  6. Oliver Takacsi-Nagy
  7. Jocelyn E Krebs
  8. Stephen M Fuchs
  9. Catherine H Freudenreich
(2019)
Distinct roles for S. cerevisiae H2A copies in recombination and repeat stability, with a role for H2A.1 threonine 126
eLife 8:e53362.
https://doi.org/10.7554/eLife.53362

Share this article

https://doi.org/10.7554/eLife.53362

Further reading

    1. Cancer Biology
    2. Chromosomes and Gene Expression
    Ananda Kishore Mukherjee, Subhajit Dutta ... Shantanu Chowdhury
    Research Article

    Telomeres are crucial for cancer progression. Immune signalling in the tumour microenvironment has been shown to be very important in cancer prognosis. However, the mechanisms by which telomeres might affect tumour immune response remain poorly understood. Here, we observed that interleukin-1 signalling is telomere-length dependent in cancer cells. Mechanistically, non-telomeric TRF2 (telomeric repeat binding factor 2) binding at the IL-1-receptor type-1 (IL1R1) promoter was found to be affected by telomere length. Enhanced TRF2 binding at the IL1R1 promoter in cells with short telomeres directly recruited the histone-acetyl-transferase (HAT) p300, and consequent H3K27 acetylation activated IL1R1. This altered NF-kappa B signalling and affected downstream cytokines like IL6, IL8, and TNF. Further, IL1R1 expression was telomere-sensitive in triple-negative breast cancer (TNBC) clinical samples. Infiltration of tumour-associated macrophages (TAM) was also sensitive to the length of tumour cell telomeres and highly correlated with IL1R1 expression. The use of both IL1 Receptor antagonist (IL1RA) and IL1R1 targeting ligands could abrogate M2 macrophage infiltration in TNBC tumour organoids. In summary, using TNBC cancer tissue (>90 patients), tumour-derived organoids, cancer cells, and xenograft tumours with either long or short telomeres, we uncovered a heretofore undeciphered function of telomeres in modulating IL1 signalling and tumour immunity.

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Bethany M Bartlett, Yatendra Kumar ... Wendy A Bickmore
    Research Article Updated

    During oncogene-induced senescence there are striking changes in the organisation of heterochromatin in the nucleus. This is accompanied by activation of a pro-inflammatory gene expression programme – the senescence-associated secretory phenotype (SASP) – driven by transcription factors such as NF-κB. The relationship between heterochromatin re-organisation and the SASP has been unclear. Here, we show that TPR, a protein of the nuclear pore complex basket required for heterochromatin re-organisation during senescence, is also required for the very early activation of NF-κB signalling during the stress-response phase of oncogene-induced senescence. This is prior to activation of the SASP and occurs without affecting NF-κB nuclear import. We show that TPR is required for the activation of innate immune signalling at these early stages of senescence and we link this to the formation of heterochromatin-enriched cytoplasmic chromatin fragments thought to bleb off from the nuclear periphery. We show that HMGA1 is also required for cytoplasmic chromatin fragment formation. Together these data suggest that re-organisation of heterochromatin is involved in altered structural integrity of the nuclear periphery during senescence, and that this can lead to activation of cytoplasmic nucleic acid sensing, NF-κB signalling, and activation of the SASP.